Reciprocal regulation of c-Src and Stat3 activation has been observed in non-small cell lung cancer cell lines (NSCLC) or tumor xenografts treated with anti-c-Src modalities and in NSCLC human patients [48]. Here, STAT3 is linked to non-small cell lung carcinoma.